TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -3 | -3 | 3 | -6 | -27 | -65 | -17 |
| S | %wins | 100 | 50 | 50 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/10/08 16:54 | 12/8/08 | OSIR | Osiris Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Carmitchel Harry E | MD | O | COO | S | -136 | 19.46 | 3 | -7 | -9 | 70 | D | -28 | 42 | 42 | 18 | 47 | 8 | -2 | 0 | -5 | 2 | 0 | -5 | -26 | -64 |
12/5/08 16:48 | 12/3/08 | OSIR | Osiris Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Carmitchel Harry E | MD | O | COO | S | -102 | 20.35 | 3 | -5 | -6 | 77 | D | -21 | 59 | 39 | 23 | 54 | 6 | 5 | -5 | 0 | -7 | 6 | -7 | -28 | -65 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |